VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,161,864 | +2.3% | 138,222 | +10.0% | 3.17% | -1.8% |
| Q1 2023 | $4,066,654 | +73.6% | 125,708 | +105.8% | 3.23% | +105.4% |
| Q1 2022 | $2,343,000 | +27.0% | 61,095 | +6.1% | 1.57% | +27.2% |
| Q4 2021 | $1,845,000 | -67.2% | 57,592 | -65.2% | 1.24% | -69.4% |
| Q2 2021 | $5,627,000 | -6.8% | 165,599 | +7.4% | 4.05% | -40.7% |
| Q3 2020 | $6,036,000 | +9.3% | 154,139 | +2.4% | 6.82% | +1.1% |
| Q2 2020 | $5,522,000 | – | 150,538 | – | 6.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |